Certain Medications Prescribed to Newborns Increasing Allergic Diseases

Pharmacy Technician

PTCB Recertification and State Required CE

START NOW

Pharmacist and Technician

Medical Therapy Management

Certificate Programs

Pharmacist: START NOW

Technician: START NOW

Certain Medications Prescribed to Newborns Increasing Allergic Diseases

Pharmacists fill them all the time -- prescriptions for acid-suppressing medications and/or antibiotics for infants in the first six months of life. Now, a new study finds that use of those drugs can raise the risk of later development of allergic diseases. How great is the risk?

BETHESDA, MD – How much is the increasing use of medications that alter the development of the human microbiome fueling the rise in allergic diseases?
That is one of the questions addressed in research published recently in JAMA Pediatrics. The article notes that both gastric acid–suppressive medications and antibiotics have been implicated as factors that may enhance the development of allergies.

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2676167

Specifically, the study led by Uniformed Services University of the Health Sciences researchers determined that the use of acid-suppressing medications or antibiotics in the first six months of infancy was linked to a heightened of risk of development of allergic diseases later in childhood.

"Allergic diseases and asthma have been on the rise over several decades," study authors note. "Medications that can alter the human microbiome may contribute to the rise of allergic diseases. Acid-suppressing medicines and antibiotics can contribute to a microbial imbalance in the gut (intestinal dysbiosis)."

To reach those conclusions, the study team focused on 792,130 children born between October 2001 and September 2013 and enrolled in the military health system for at least their first year of life.

Factors considered in the observational study were any dispensed prescription for a histamine-2 receptor antagonist (H2RA), proton pump inhibitor (PPI) or antibiotic (exposures) in the first six months of life and diagnosis of allergic disease, defined as the presence of food allergy, anaphylaxis, asthma, atopic dermatitis, allergic rhinitis. allergic conjunctivitis, urticaria, contact dermatitis, medication allergy or other allergies.

Results indicate that the use of acid-suppressing medicines was associated with increased risks for all major categories of allergic disease, especially food allergy. The researchers also found that antibiotics also were associated with increased risk of all major categories for allergic disease.

Specifically, of 792 130 children included for analysis, 7.6% were prescribed an H2RA, 1.7% were prescribed a PPI, and 16.6% were prescribed an antibiotic during the first six months of life. The study reports that adjusted hazard ratios (aHRs) in children prescribed H2RAs and PPIs, respectively, were:

  • 2.18 (95% CI, 2.04-2.33) and 2.59 (95% CI, 2.25-3.00) for food allergy,
  • 1.70 (95% CI, 1.60-1.80) and 1.84 (95% CI, 1.56-2.17) for medication allergy,
  • 1.51 (95% CI, 1.38-1.66) and 1.45 (95% CI, 1.22-1.73) for anaphylaxis,
  • 1.50 (95% CI, 1.46-1.54) and 1.44 (95% CI, 1.36-1.52) for allergic rhinitis, and
  • 1.25 (95% CI, 1.21-1.29) and 1.41 (95% CI, 1.31-1.52) for asthma.

As for antibiotic prescriptions in the first six months of life, aHRs were 2.09 (95% CI, 2.05-2.13) for asthma, 1.75 (95% CI, 1.72-1.78) for allergic rhinitis, 1.51 (95% CI, 1.38-1.66) for anaphylaxis, and 1.42 (95% CI, 1.34-1.50) for allergic conjunctivitis.

In light of their findings, study authors recommend, "Acid-suppressive medications and antibiotics should be used during infancy only in situations of clear clinical benefit."

Related CE

Itching to Improve Allergic Rhinitis Management? Tips for Patient Care
http://www.powerpak.com/course/preamble/115544

Maximizing Patient Interaction at the Pharmacy Counter OTC Medications for Allergic Rhinitis and the Common Cold
http://www.powerpak.com/course/preamble/114121

Providing Relief to Patients with Atopic Dermatitis: How Pharmacists Can Help—Article
http://www.powerpak.com/course/preamble/115830

Providing Relief to Patients with Atopic Dermatitis: How Pharmacists Can Help
http://www.powerpak.com/course/preamble/115537

Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing education for the broad spectrum of health care professionals. This site features a searchable database of accredited Power-Pak C.E.® courses on important topics for today's health care professionals.

PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new courses available on the site.